Stock Events

Stock Events

Shuttle Pharmaceuticals 

$5.15
22
-$0.08-1.53%Friday 20:00
-$0.10-1.94%Friday 20:38After hours

Statistics

Day High
5.25
Day Low
5.25
52W High
44.4
52W Low
2.58
Volume
16,350
Avg. Volume
-
Mkt Cap
24.54M
P/E Ratio
29.6
Dividend Yield
-
Dividend
-

Earnings

Nov 20Expected
Q3 2016
Q1 2017
Q2 2017
Q3 2017
-0.01
-0.01
-0
0
Expected EPS
0
Actual EPS
0

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-11.72MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHPH. It's not an investment recommendation.
Lloyds Banking Group
5
LLOY.LSE
National Grid
5
NG.LSE
Aviva
5
AV.LSE
Barclays
5
BARC.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines for many of the same diseases targeted by Shuttle Pharmaceuticals, making them direct competitors in the pharmaceutical market.
Pfizer
PFE
Mkt Cap158.45B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including medicines and vaccines, competing in similar therapeutic areas as Shuttle Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb Company is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, overlapping with Shuttle Pharmaceuticals' mission.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson is a comprehensive healthcare firm that produces pharmaceuticals, medical devices, and consumer health products, competing across several of Shuttle Pharmaceuticals' key areas.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie Inc. is a research-based biopharmaceutical company that develops and markets advanced therapies, directly competing with Shuttle Pharmaceuticals in the area of drug development and innovation.
AMGEN
AMGN
Mkt Cap217.9B
Amgen Inc. is a biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics, making it a competitor in the biopharmaceutical field alongside Shuttle Pharmaceuticals.
Gilead Sciences
GILD
Mkt Cap179.47B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet medical need, directly competing with Shuttle Pharmaceuticals.
Novartis
NVS
Mkt Cap268B
Novartis AG is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing with Shuttle Pharmaceuticals in various therapeutic areas.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics. It is a direct competitor in the development of innovative drugs and personalized healthcare solutions.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, competing in similar fields as Shuttle Pharmaceuticals.

About

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
Show More
CEO
Christopher Robert Cooper
Employees
2
Country
United States
ISIN
US8256935003

Listings

XNAS
US
SHPH
BOATS
BOATS
SHPH.BOATS

0 Comments

Share your thoughts

FAQs

What is Shuttle Pharmaceuticals stock price today?▼
The current price of SHPH is $5.15 USD — it has decreased by -1.53% in the past 24 hours. Watch Shuttle Pharmaceuticals stock price performance more closely on the chart.
What is Shuttle Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Shuttle Pharmaceuticals stocks are traded under the ticker SHPH.
Is Shuttle Pharmaceuticals stock price growing?▼
SHPH stock has risen by +5.97% compared to the previous week, the month change is a +30.38% rise, over the last year Shuttle Pharmaceuticals has showed a -82.66% decrease.
What is Shuttle Pharmaceuticals market cap?▼
Today Shuttle Pharmaceuticals has the market capitalization of 24.54M
What were Shuttle Pharmaceuticals earnings last quarter?▼
SHPH earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Shuttle Pharmaceuticals revenue for the last year?▼
Shuttle Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Shuttle Pharmaceuticals net income for the last year?▼
SHPH net income for the last year is -11.72M USD.
How many employees does Shuttle Pharmaceuticals have?▼
As of November 1, 2026, the company has 2 employees.
In which sector is Shuttle Pharmaceuticals located?▼
Shuttle Pharmaceuticals operates in the Health & Wellness sector.
When did Shuttle Pharmaceuticals complete a stock split?▼
The last stock split for Shuttle Pharmaceuticals was on June 11, 2026 with a ratio of 1:10.
Where is Shuttle Pharmaceuticals headquartered?▼
Shuttle Pharmaceuticals is headquartered in GAITHERSBURG, United States.